Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-03-18 00:59:14

expired found date

-

created at

2024-06-25 02:34:39

updated at

2025-04-20 09:51:13

Domain name statistics

length

18

crc

58165

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

256482523

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

135779

mp size raw text

13859

mp inner links count

0

mp inner links status

1 (no links)

Open Graph

title

Biotechnology - Access Industries

description

site name

Access Industries

author

updated

2026-01-01 10:18:44

raw text

Biotechnology - Access Industries Skip to content Home Our Story Leadership Holdings Menu Close Menu Close Home Main Menu Holdings Biotechnology Entertainment External Funds Global Media Real Estate Strategic Equity Technology Ventures Our Story Leadership News Blavatnik Family Foundation Investing in Life-Changing New Medicines Access Biotechnology by numbers 2019 established Led by former head of worldwide clinical R&D at Pfizer, Liam Ratcliffe. 25+ investments A portfolio of private and public biopharma investments. 5+ exits Access has backed high-quality small biotech firms that have been acquired by large pharma. Access Biotechnology invests in transformative therapies for conditions with high unmet needs and that have the potential to meaningfully impact human health. Our approach is characterized by the following: Broad Scope We invest in both private and public biopharma companies across therapeutic a...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Medycyna (36)

index version

2025123101

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

11133

text words

1901

text unique words

532

text lines

255

text sentences

114

text paragraphs

16

text words per sentence

16

text matched phrases

36

text matched dictionaries

4

RSS

rss status

32 (unknown)

rss found date

2024-03-18 01:04:56

rss size orig

23011

rss items

10

rss spam phrases

0

rss detected language

1 (English)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap path

sitemap status

1 (priority 1 already searched, no matches found)

sitemap review version

2

sitemap urls count

0

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

-

sitemap process date

-

sitemap first import date

-

sitemap last import date

-